(Q47244655)

12 January 2018

title

Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients. A prospective cohort study (English)

1 reference

12 January 2018

1 reference

1 reference

Crowther MA

1

1 reference

12 January 2018

Spitzer K

2

1 reference

12 January 2018

Julian J

3

1 reference

12 January 2018

Ginsberg J

4

1 reference

12 January 2018

Johnston M

5

1 reference

12 January 2018

Crowther R

6

1 reference

12 January 2018

Laskin C

7

1 reference

12 January 2018

publication date

1 April 2000

1 reference

12 January 2018

published in

Thrombosis Research

1 reference

12 January 2018

volume

98

1 reference

12 January 2018

issue

2

1 reference

12 January 2018

page(s)

133-138

1 reference

12 January 2018

Anticoagulants in pregnancy: fetal effects

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

Prophylaxis of postoperative thromboembolism with low molecular weight heparins.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

Placental transport of low molecular weight heparin in the pregnant sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

Thromboembolic prophylaxis with low molecular weight heparin during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

Prednisone and Aspirin in Women with Autoantibodies and Unexplained Recurrent Fetal Loss

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

An approach to the analysis of repeated measurements.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

Tinzaparin. A review of its pharmacology and clinical potential in the prevention and treatment of thromboembolic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

No transplacental passage of standard heparin or an enzymatically depolymerized low molecular weight heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900228-5

7 January 2021

10.1016/S0049-3848(99)00228-5

Identifiers

DOI

1 reference

12 January 2018

1 reference

12 January 2018